Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2020, Vol. 52 ›› Issue (2): 214-220. doi: 10.19723/j.issn.1671-167X.2020.02.004

Previous Articles     Next Articles

Interaction between PSF and cytokeratin 18 mediates PSF relocation to cell membrane and maintains chemosensitivity of myeloid leukemia

Si-mei REN1,2,△(),Lu-yao LONG1,2,Cheng-shan XU1   

  1. 1. National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China
    2. Graduate School of Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
  • Received:2019-12-09 Online:2020-04-18 Published:2020-04-18
  • Contact: Si-mei REN E-mail:rensimei4162@bjhmoh.cn
  • Supported by:
    Supported by the National Natural Science Foundation of China(81670161);Research Projects of Beijing Hospital(BJ-2015-105)

RICH HTML

 9   

PDF (PC)

259

Abstract:

Objective: To identify the chaperone of polypyrimidine tractor-binding protein-associated splicing factor (PSF) in myeloid leukemia cells, and to explore the mechanism and redistributive pattern to cell surface of PSF in chemo-sensitive HL60 cells and resistant HL60/DOX cells.Methods: The eukaryotic expression vector of PSF was transfected with liposomes transiently, then flow cytometry was used to detect the expression level of PSF on the cell surface 24 h, 48 h and 72 h after vector transfections. We constructed a chimeric expression vector, streptavidin binding peptide (SBP)-PSF, meanwhile this vector was transfected and made SBP-PSF fusion protein overexpress. In addition, we used streptavidin magnetic beads to precipitate the cellular chaperonin of PSF and then identified its chaperonin by mass spectrometry (MS). Lentiviral vectors containing cytokeratin18 (K18) interference sequences were transfected into 293T cells to prepare lentivirus. HL60 and HL60/DOX cells were infected with lentivirus to obtain stable interfering K18 cell lines. Next, flow cytometry was used to test the membrane relocation level of PSF. Together, these methods confirmed the similar or different mechanisms of the PSF redistributing to membrane synergistically mediated by K18 in HL60 and HL60/DOX cells.Results: The expression of membrane relocated PSF was detected every day for three days(at the end of 24 h,48 h and 72 h) after transient overexpression. The expressing rate of PSF on the cell surface was 22.4%±3.5%, 37.9%±6.0%, 58.3%±8.8%, respectively in sensitive HL60 cells, while that was 4.7%±0.5%, 3.9%±0.6%, 2.9%±0.6% , respectively in resistant HL60/DOX cells. The difference of expressing rate on each day was significant, P<0.01. We identified K18 detected by co-immunoprecipitation and mass spectrum assay which was the cellular chaperone of PSF. We found that K18 knockdown decreased the PSF expression level which redistributed on cell surface from 48.9%±5.4% to 6.2%±1.0% in sensitive HL60 cells, and from 9.11%±1.2% to 2.21%±0.51% in resistant HL60/DOX cells, respectively.Conclusion: K18 is the intracellular chaperonin of PSF. The interaction of PSF and K18 mediates its redistribution to cell membrane in sensitive cells. While in resistant cells, PSF failed to relocate at the cell surface and accumulated in cells, which mediated resistance to chemotherapeutics.

Key words: Tumor multidrug resistance, Polypyrimidine tract-binding protein-associated splicing factor, Cytokeratin 18

CLC Number: 

  • R557.1

Figure 1

Characteristics of HL60 and HL60/DOX A, cell viability of HL60 and HL60/DOX cells were detected by MTS assay; B, transcriptional and protein expression level of PSF in HL60 and HL60/DOX cells."

Figure 2

Ability of PSF to migrate to the cell membrane A, fragment inserted at a polyclonal site of pcDNA3.0 vector and working panel of experiment; B, HL60 and HL60/DOX were transfected with pcDNA3 vector containing HA-PSF fusion fragment, PSF expression on cell surface was detected by flow cytometry (△P<0.01). PSF, polypyrimidine tract-binding protein-associated splicing factor; PSF-FL, PSF full length."

Figure 3

K18 is the intracellular chaperone of PSF A, HL60 cells were transfected with SBP-PSF-pcDNA3.0 vector. Avidin magnetic beads were used for immunoprecipitation from whole lysates of HL60 cells. The precipitated proteins (arrow) were separated by 12% SDS-PAGE and visualized by Commassie blue staining; B, protein precipitation complexes were identified by mass spectrometry; C, reciprocal experiment between CO-IP and Western blot. CO-IP, co-immunoprecipitation; PSF, polypyrimidine tract-binding protein-associated splicing factor; SBP, streptavidin binding peptide; K18, cytokeratin 18."

Figure 4

PSF membrane expression assay after K18 interference A, transcriptional expression levels of K18 in sensitive and resistant HL60 cells, *P<0.05; B, K18 transcriptional expression levels after K18 knockdown in HL60 cells,# P<0.001; C, PSF expression on cell surface after K18 knockdown were detected by flow cytometry. PSF, polypyrimidine tract-binding protein-associated splicing factor; K18, cytokeratin 18."

[1] Kulkoyluoglu-Cotul E, Smith BP, Wrobel K , et al. Combined targeting of estrogen receptor Alpha and XPO1 prevent akt activation, remodel metabolic pathways and induce autophagy to overcome tamoxifen resistance[J]. Cancers (Basel), 2019,11(4):479.
[2] Ren S, She M, Li M , et al. The RNA/DNA-binding protein PSF relocates to cell membrane and contributes cells' sensitivity to antitumor drug, doxorubicin[J]. Cytometry A, 2014,85(3):231-241.
[3] Knott GJ, Bond CS, Fox AH . The DBHS proteins SFPQ, NONO and PSPC1: A multipurpose molecular scaffold[J]. Nucleic Acids Res, 2016,44(9):3989-4004.
[4] Gao Z, Chen M, Tian X , et al. A novel human lncRNA SANT1 cis-regulates the expression of SLC47A2 by altering SFPQ/E2F1/HDAC1 binding to the promoter region in renal cell carcinoma[J]. RNA Biol, 2019,16(7):940-949.
[5] de Silva HC, Lin MZ, Phillips L , et al. IGFBP-3 interacts with NONO and SFPQ in PARP-dependent DNA damage repair in triple-negative breast cancer[J]. Cell Mol Life Sci, 2019,76(10):2015-2030.
[6] Takayama K I, Suzuki T, Fujimura T , et al. Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF[J]. Proc Natl Acad Sci USA, 2017,114(39):10461-10466.
[7] Yarosh CA, Iacona JR, Lutz CS , et al. PSF: nuclear busy-body or nuclear facilitator?[J]. Wiley Interdiscip Rev RNA, 2015,6(4):351-367.
[8] Izumi H, Mccloskey A, Shinmyozu K , et al. p54nrb/NonO and PSF promote U snRNA nuclear export by accelerating its export complex assembly[J]. Nucleic Acids Res, 2014,42(6):3998-4007.
[9] Duan Y, Sun Y, Zhang F , et al. Keratin K18 increases cystic fibrosis transmembrane conductance regulator (CFTR) surface expression by binding to its C-terminal hydrophobic patch[J]. J Biol Chem, 2012,287(48):40547-40559.
[10] Chen J, Ouyang H, An X , et al. Vault RNAs partially induces drug resistance of human tumor cells MCF-7 by binding to the RNA/DNA-binding protein PSF and inducing oncogene GAGE6[J]. PLoS One, 2018,13(1):e0191325.
[11] Wang G, Cui Y, Zhang G , et al. Regulation of proto-oncogene transcription, cell proliferation, and tumorigenesis in mice by PSF protein and a VL30 noncoding RNA[J]. Proc Natl Acad Sci USA, 2009,106(39):16794-16798.
[12] Wang XT, Xia QY, Ni H , et al. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion[J]. Hum Pathol, 2017,63:190-200.
[13] Ishikawa N, Nagase M, Takami S , et al. Xp11.2 translocation renal cell carcinoma with SFPQ/PSF-TFE3 fusion gene: A case report with unusual histopathologic findings[J]. Pathol Res Pract, 2019,215(9):152479.
[14] Ha K, Takeda Y, Dynan WS . Sequences in PSF/SFPQ mediate radioresistance and recruitment of PSF/SFPQ-containing complexes to DNA damage sites in human cells[J]. DNA Repair (Amst), 2011,10(3):252-259.
[15] Zou Y, He L, Wu CH , et al. PSF is an IbeA-binding protein contributing to meningitic Escherichia coli K1 invasion of human brain microvascular endothelial cells[J]. Med Microbiol Immunol, 2007,196(3):135-143.
[16] Toivola DM, Boor P, Alam C , et al. Keratins in health and disease[J]. Curr Opin Cell Biol, 2015,32:73-81.
[17] Ramot Y, Zlotogorski A . Keratins: the hair shaft's backbone revealed[J]. Exp Dermatol, 2015,24(6):416-417.
[18] Lee S Y, Kim S, Lim Y , et al. Keratins regulate Hsp70-mediated nuclear localization of p38 mitogen-activated protein kinase[J/OL]. J Cell Sci, 2019, 9(2019-09-26)[2019-11-09].
[19] Zhang B, Wang J, Liu W , et al. Cytokeratin 18 knockdown decreases cell migration and increases chemosensitivity in non-small cell lung cancer[J]. J Cancer Res Clin Oncol, 2016,142(12):2479-2487.
[20] Shi R, Wang C, Fu N , et al. Downregulation of cytokeratin 18 enhances BCRP-mediated multidrug resistance through induction of epithelial-mesenchymal transition and predicts poor prognosis in breast cancer[J]. Oncol Rep, 2019,41(5):3015-3026.
No related articles found!
Viewed
Full text
268
HTML PDF
Just accepted Online first Issue Just accepted Online first Issue
0 0 9 0 0 259

  From Others local
  Times 36 232
  Rate 13% 87%

Abstract
1058
Just accepted Online first Issue
0 0 1058
  From Others local
  Times 1047 11
  Rate 99% 1%

Cited
Web of Science  Crossref   ScienceDirect  Search for Citations in Google Scholar >>
 
This page requires you have already subscribed to WoS.
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd